Fintel reports that on March 31, 2026, William Blair upgraded their outlook for 10x Genomics (NasdaqGS:TXG) from Market Perform to Outperform. Analyst Price Forecast Suggests 4.45% Upside As of March ...

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings this Thursday after market hours. Here’s what investors should know. 10x Genomics beat analysts’ revenue expectations by 4.6% last ...

We recently published 10 Stocks Beating the Market with Eye-Popping Gains. 10x Genomics Inc. (NASDAQ:TXG) is one of the best-performing stocks on Monday. Shares of 10x Genomics propelled to a new ...

Lancaster Investment Management bought over 620,000 shares in 10x Genomics (TXG) worth around $7.27 million. 10x Genomics, a new holding for the investment manager, now accounts for 3.1% of its AUM.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Investors in 10x Genomics Inc (Symbol: TXG) saw new options become available this week, for the May 2025 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, ...

Fintel reports that on June 26, 2024, Guggenheim downgraded their outlook for 10x Genomics (NasdaqGS:TXG) from Buy to Neutral. Analyst Price Forecast Suggests 109.23% Upside As of June 12, 2024, the ...